Standout Papers

Etrasimod as induction and maintenance therapy for ulcerative colitis (ELEVATE): two randomised, double-blind, placebo-controlled, phase... 2023 2026 2024175
  1. Etrasimod as induction and maintenance therapy for ulcerative colitis (ELEVATE): two randomised, double-blind, placebo-controlled, phase 3 studies (2023)
    William J. Sandborn, Séverine Vermeire et al. The Lancet

Immediate Impact

1 from Science/Nature 28 standout
Sub-graph 1 of 9

Citing Papers

A systematic framework for understanding the microbiome in human health and disease: from basic principles to clinical translation
2024 Standout
Roles, Users, Benefits, and Limitations of Chatbots in Health Care: Rapid Review
2024 Standout
2 intermediate papers

Works of Timothy E. Ritter being referenced

Recurrent Clostridioides difficile infection worsens anxiety-related patient-reported quality of life
2022
Challenges in Using Real-world Clinical Practice Records for Validation of Clinical Trial Data in Inflammatory Bowel Disease: Lessons Learned
2017

Author Peers

Author Last Decade Papers Cites
Timothy E. Ritter 256 202 85 103 38 404
Marta Vernero 220 189 94 109 36 451
Bénédicte Caron 221 162 85 99 49 423
Katia El Jurdi 232 183 34 92 27 371
Jacob Broder Brodersen 205 127 148 104 24 456
Takahiko Toyonaga 240 222 68 100 30 420
M. Fekih 248 198 82 146 52 411
Evanthia Zampeli 178 136 123 117 26 364
Ivan Ferkolj 265 182 108 116 23 403
Kamila Stawczyk‐Eder 262 167 71 124 40 381
Gaurav Syal 261 235 46 158 47 407

All Works

Loading papers...

Rankless by CCL
2026